Global risk classification and clinical SYNTAX (Synergy between Percutaneous Coronary Inter- vention with TAXUS and Cardiac Surgery) score in patients undergoing percutaneous or surgical left main revascularization. J Am Coll Cardiol Intv. 2011;4:287 97. 320. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331 41. 321. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994 1996. Circulation. 1997;96: 3867 72. 322. Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing per- cutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J. 2008;155:274 83. 323. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis [published correction appears in J Am Coll Cardiol. 2011;57:1792]. J Am Coll Cardiol. 2011;57:538 45. 324. Brener SJ, Galla JM, Bryant RI, et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol. 2008;101: 169 72. 325. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113: 2542 7. 326. Chieffo A, Magni V, Latib A, et al. 5 year outcomes following per- cutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: the Milan experience. J Am Coll Cardiol Intv. 2010;3: 595 601. 327. Lee MS, Kapoor N, Jamal F, et al. 